Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)

A high body mass index (BMI) is associated with increased cardiovascular risk. We sought to identify whether BMI influences the choice of lipid‐lowering treatment in a large, real‐world cohort of 52 916 patients treated with statins. The Dyslipidemia International Study (DYSIS) is a cross‐sectional,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrières, Jean, Lautsch, Dominik, Gitt, Anselm K., De Ferrari, Gaetano, Toplak, Hermann, Elisaf, Moses, Drexel, Heinz, Horack, Martin, Baxter, Carl, Ambegaonkar, Baishali, Brudi, Philippe, Toth, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220851/
https://www.ncbi.nlm.nih.gov/pubmed/29888459
http://dx.doi.org/10.1111/dom.13415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220851/
https://www.ncbi.nlm.nih.gov/pubmed/29888459
http://dx.doi.org/10.1111/dom.13415

Ejemplares similares